Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

2.17%

23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

First 20 Last

Share
Profile

Follow
TanamiRod

542 Posts.

208

30/04/24

19:46

Post #: 73592959
Share

Originally posted by Gan_Gans: ↑

it seems lower doses accelerate disease progression on some biomarkers, and PGIC.

The std dev on the presentations suggest the 2mg/kg has some big nett negative effect on some patients. Std dev is 2 sigma - so I now understand the FDA hesitancy. it’s not one rat.

Expand

GG, what presentations are you referring to please?

PAR Price at posting: 27.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 15 more messages in this thread...

First 20 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 23.5¢		Change 0.005(2.17%)		Mkt cap ! $83.95M

Open	High	Low	Value	Volume
23.5¢	24.0¢	23.3¢	$98.97K	420.0K

Buyers (Bids)

No.	Vol.	Price($)
5	108680	23.5¢

Sellers (Offers)

Price($)	Vol.	No.
24.0¢	35486	6

View Market Depth

No.	Vol.	Price($)
5	108680	0.235
15	116687	0.230
2	9810	0.225
7	185300	0.220
5	112966	0.215

Price($)	Vol.	No.
0.240	35486	6
0.245	85637	6
0.250	56368	4
0.255	61772	5
0.260	122632	8

Last trade - 15.06pm 14/06/2024 (20 minute delay)


Last 23.5¢			Change 0.005 ( 2.17 %)
Open	High		Low	Volume
23.5¢	24.0¢		23.5¢	63707
Last updated 15.19pm 14/06/2024 ?

PAR (ASX) Chart